October 16, 2013

Several New Risks Emerge For Women Taking Hormone Replacement Drugs

Blog

Hormone replacement therapy (HRT) drugs are a popular therapeutic option for women going through menopause.

View More

October 16, 2013

Critical Products Liability Debate Highlights Supreme Ct. Arguments

News

By Max Mitchell, PA Law Weekly WriterThe state Supreme Court is set to hear whether the Restatement (Second) of Torts or the Restatement (Third) of Torts should govern Pennsylvania products liability at oral arguments today in Pittsburgh.

View More

October 09, 2013

Just how many people die from medical mistakes in American hospitals?

Blog

Just how many people die from medical mistakes in American hospitals? As Scientific American recently explained, researchers have struggled to establish an accurate figure for decades.

View More

October 04, 2013

Gil Marquez to Address Technology for Lawyers at Bench-Bar & Annual Conference in Atlantic City

News

Event Location: REVEL Atlantic City Technology Tips for Managing Your Practice: From Desktop to Mobile Gilbert J.

View More

October 02, 2013

After Tort Reform: Texas Doctors Operate without Oversight

Blog

Largely in line with the mission of this firm, pro-civil justice blog The Pop Tort recently featured an article about regulation in the health care industry, writing that “deregulation and lax regulatory enforcement [seem] to have become a national goal.

View More

September 25, 2013

FDA Delays on Sutent Side Effects Warning

Blog

Sutentis a drug manufactured by Pfizer is prescribed by doctors to treat cancer of the pancreas, stomach, bowels, and kidney.

View More

September 18, 2013

Anti-Epilepsy Drugs Pose Health Risks to Some Patients, Many Doctors Unaware

Blog

A study published on August 14 by Johns Hopkins Medicine (in the journal Epilepsy and Behavior) suggests that American neurologists’ pharmaceutical knowledge may be lacking.

View More

September 11, 2013

House-Approved REINS Act Threatens to Stall Regulation and Oversight

Blog

Imagine a nation in which every “economically significant” regulatory measure–whether related to healthcare, environmental protection, air travel, pharmaceutical oversight, or even Wall Street banking–were subject to a yes-or-no vote from one of the most polarized and gridlocked Congresses in history.

View More


September 04, 2013

Prolific Plastic Products Pose Problems — FDA Fails Again

Blog

Early this past spring, we published an article titled “The Slip between the Cup and the Lip: The FDA’s Lax Regulation of Potentially Harmful Products,” which elaborated on yet another example of the relative inability of the FDA to regulate products and chemicals that may pose a threat to the health of consumers (and in this instance, children).

View More

August 28, 2013

On Roller Coasters and Regulation

Blog

In May of this year, we posted an article about the surprising prevalence of injuries to children at amusement parks.

View More

August 21, 2013

Doctors Receiving Kickbacks May Be Persuaded to Prescribe

Blog

The blog aboutlawsuits.

View More